Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XONE
2976
DELISTED
The ExOne Company
XONE
| $522K | ﹤0.01% |
55,981
+15,947
| +40% | +$131K |
|
|
SUP
2977
DELISTED
Superior Industries International
SUP
| $521K | ﹤0.01% |
+150,700
| New | +$693K |
|
|
SBBP
2978
DELISTED
Strongbridge Biopharma plc.
SBBP
| $521K | ﹤0.01% |
166,300
+112,300
| +208% | +$412K |
|
2979
OptimizeRx
OPRX
$165M
| $520K | ﹤0.01% |
+32,100
| New | +$433K |
|
2980
LiqTech
LIQT
$20M
| $519K | ﹤0.01% |
+6,550
| New | +$450K |
|
2981
FreightCar America
RAIL
$243M
| $517K | ﹤0.01% |
88,000
+75,500
| +604% | +$487K |
|
2982
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$6.05B
| $515K | ﹤0.01% |
+29,000
| New | +$503K |
|
2983
Amneal Pharmaceuticals
AMRX
$6.15B
| $514K | ﹤0.01% |
71,700
-315,700
| -81% | -$3.23M |
|
|
TMQ
2984
Trilogy Metals
TMQ
$650M
| $512K | ﹤0.01% |
173,400
+28,700
| +20% | +$75.9K |
|
|
MDC
2985
DELISTED
M.D.C. Holdings, Inc.
MDC
| $512K | ﹤0.01% |
16,865
-299,626
| -95% | -$8.82M |
|
|
DESP
2986
DELISTED
Despegar.com
DESP
| $510K | ﹤0.01% |
36,700
-42,000
| -53% | -$574K |
|
|
SNNA
2987
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
| $510K | ﹤0.01% |
586,294
+281,094
| +92% | +$440K |
|
|
SDPI
2988
DELISTED
Superior Drilling Products Inc.
SDPI
| $509K | ﹤0.01% |
504,446
+99,700
| +25% | +$107K |
|
2989
Highway Holdings
HIHO
$5.04M
| $508K | ﹤0.01% |
180,827
-20,500
| -10% | -$60.6K |
|
|
TREC
2990
DELISTED
Trecora Resources
TREC
| $507K | ﹤0.01% |
52,985
+1,200
| +2% | +$11.4K |
|
|
MNTX
2991
DELISTED
Manitex International, Inc.
MNTX
| $507K | ﹤0.01% |
+83,040
| New | +$567K |
|
|
NOTV
2992
DELISTED
Inotiv
NOTV
| $506K | ﹤0.01% |
253,001
+18,120
| +8% | +$36.1K |
|
2993
ZK International Group
ZKIN
$62.4M
| $503K | ﹤0.01% |
50,540
+23,977
| +90% | +$260K |
|
|
AFBI
2994
DELISTED
Affinity Bancshares
AFBI
| $501K | ﹤0.01% |
45,708
+6,025
| +15% | +$67.1K |
|
2995
Direxion Daily FTSE China Bear 3X ETF
YANG
$99.3M
| $500K | ﹤0.01% |
+545
| New | +$532K |
|
2996
Mannatech
MTEX
$9.78M
| $499K | ﹤0.01% |
29,397
+6,000
| +26% | +$104K |
|
|
PRTK
2997
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $499K | ﹤0.01% |
125,149
-162,700
| -57% | -$774K |
|
2998
FTAI Aviation
FTAI
$23.3B
| $498K | ﹤0.01% |
+38,643
| New | +$528K |
|
2999
Wave Life Sciences
WVE
$1.02B
| $498K | ﹤0.01% |
19,100
+10,854
| +132% | +$304K |
|
|
PPLT
3000
abrdn Physical Platinum Shares ETF
PPLT
$2B
| $497K | ﹤0.01% |
+63,000
| New | +$503K |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.